Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

Pasi Antero Janne, Alice Tsang Shaw, José Rodrigues Pereira et al. · The Lancet Oncology · 2012

Cited by 657 works. doi:10.1016/s1470-2045(12)70489-8

Authors

References